A Pennsylvania federal judge on Friday certified a class of direct purchasers of Suboxone as well as a class of end payors in multidistrict litigation over an alleged product-hopping scheme by Indivior PLC to block generic versions of the opioid treatment drug from coming to market…

Read this piece in its entirety at Law360.